Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00139269 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Advanced Squamous Cell Carcinoma
Squamous Cell Carcinoma of Head and Neck
SSCHN

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: 5-Fluorouracil

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]